Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis
- 6 February 2017
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 74, 17-25
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Breast cancer brain metastases: the last frontierExperimental Hematology & Oncology, 2015
- Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomyCancer Medicine, 2015
- Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain MetastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatmentJournal of Neuro-Oncology, 2011
- Relationship Between Neurocognitive Function and Quality of Life After Whole-Brain Radiotherapy in Patients With Brain MetastasisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Brain metastases in breast cancer: prognostic factors and managementBreast Cancer Research and Treatment, 2007
- Treatment and prognosis of brain metastases from breast cancerJournal of Neuro-Oncology, 2007
- Prognostic Significance of Human Epidermal Growth Factor Receptor Positivity for the Development of Brain Metastasis After Newly Diagnosed Breast CancerJournal of Clinical Oncology, 2006
- Primary breast cancer phenotypes associated with propensity for central nervous system metastasesCancer, 2006
- Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)Annals of Oncology, 2006